astragaloside a has been researched along with Body Weight in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, F; Lin, X; Qi, M; Sun, S; Wang, Q; Wu, Q; Xu, G; Yu, J | 1 |
| Fang, L; Li, H; Li, Z; Lin, J; Lyu, L; Wang, H; Xiao, J | 1 |
| Cai, GJ; Chen, YF; Fan, R; Gao, Y; Hou, MX; Shi, GB; Song, J; Wang, Q; Wang, TC; Yang, C; Zhang, W | 1 |
| Gao, Y; Hu, ZB; Huang, F; Lan, YY; Qin, LY; Shi, HL; Wu, H; Wu, XJ; Zhang, BB | 1 |
| Du, H; Han, P; Li, S; Shao, M; Song, G; Sun, H; Wang, W; Yi, T | 1 |
| Li, X; Liu, H; Sun, WY; Wei, W | 1 |
| Liu, ZQ; Lv, L; Pang, JX; Rao, JJ; Wang, GF; Wu, SG; Wu, SY; Xu, W; Zhang, JJ | 1 |
| Mao, SL; Wang, XH; Zhang, N; Zhao, F | 1 |
| Jiang, S; Qiu, J; Shen, J; Sun, S; Yin, H; Yin, X; Yu, J; Zhang, Y | 1 |
9 other study(ies) available for astragaloside a and Body Weight
| Article | Year |
|---|---|
Astragaloside IV promotes the eNOS/NO/cGMP pathway and improves left ventricular diastolic function in rats with metabolic syndrome.
Topics: Animals; Aspartate Aminotransferases; Biomarkers; Blood Pressure; Body Weight; Cyclic GMP; Diastole; Diet, High-Fat; Electrocardiography; Fructose; Glucose; Hemodynamics; Insulin; Lipid Metabolism; Male; Metabolic Syndrome; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Protein Multimerization; Rats, Sprague-Dawley; Saponins; Signal Transduction; Systole; Triglycerides; Triterpenes; Ventricular Function, Left | 2020 |
Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress.
Topics: Animals; Body Weight; Cardiomyopathies; Cardiotoxicity; Cell Size; Doxorubicin; Gene Expression Regulation; Male; Mice; Myocytes, Cardiac; NADPH Oxidase 2; NADPH Oxidase 4; Organ Size; Oxidative Stress; Rats; Saponins; Triterpenes | 2019 |
Antinociceptive activity of astragaloside IV in the animal model of chronic constriction injury.
Topics: Analgesics; Animals; Body Weight; Chronic Pain; Constriction, Pathologic; Disease Models, Animal; Ganglia, Spinal; Hot Temperature; Hyperalgesia; Male; Motor Activity; Necrosis; Neural Conduction; Neuralgia; Rats, Sprague-Dawley; Saponins; Sciatic Nerve; Touch; Triterpenes | 2015 |
Astragaloside IV improves lipid metabolism in obese mice by alleviation of leptin resistance and regulation of thermogenic network.
Topics: Adipose Tissue; Animals; Body Weight; Cell Line; Diet, High-Fat; Gene Expression; Leptin; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Receptors, Leptin; Saponins; Thermogenesis; Triglycerides; Triterpenes; Weight Gain | 2016 |
Astragaloside IV ameliorates renal injury in db/db mice.
Topics: Acetylglucosamine; Albuminuria; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Glomerular Filtration Rate; Glycated Hemoglobin; Hypertrophy; Kidney; Lipocalin-2; Liver; Mice; Phosphorylation; Saponins; Signal Transduction; Transforming Growth Factor beta1; Triterpenes | 2016 |
Protective effects of astragaloside IV on porcine-serum-induced hepatic fibrosis in rats and in vitro effects on hepatic stellate cells.
Topics: Alanine Transaminase; Animals; Astragalus Plant; Body Weight; Collagen; Collagen Type III; Hepatic Stellate Cells; Humans; Hyaluronic Acid; Hydroxyproline; Liver; Liver Cirrhosis; Male; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Saponins; Transforming Growth Factor beta1; Triterpenes | 2009 |
Effect of astragaloside IV on hepatic glucose-regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Glucose-6-Phosphatase; Glycogen Phosphorylase; Hypoglycemic Agents; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Saponins; Streptozocin; Triglycerides; Triterpenes | 2010 |
Astragaloside IV improves metabolic syndrome and endothelium dysfunction in fructose-fed rats.
Topics: Animals; Blood Pressure; Body Weight; Cyclic GMP; Endothelium, Vascular; Fructose; Glucose Tolerance Test; Male; Malondialdehyde; Metabolic Syndrome; Rats; Rats, Sprague-Dawley; Saponins; Triterpenes; Vasodilation | 2011 |
Inhibitory effects of astragaloside IV on diabetic peripheral neuropathy in rats.
Topics: Adenosine Triphosphatases; Aldehyde Reductase; Animals; Behavior, Animal; Blood Glucose; Body Weight; Cation Transport Proteins; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Erythrocytes; Glutathione Peroxidase; Glycated Hemoglobin; Glycation End Products, Advanced; Insulin; Models, Biological; Motor Activity; Pain Measurement; Rats; Rats, Sprague-Dawley; Saponins; Sural Nerve; Triterpenes | 2006 |